SCHEMBL7989313

SCHEMBL7989313

COc1cccc(Cn2cnc3nc(-c4ccncc4)nc(O)c32)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 10/20 0.52
ROCK1 Q13464 8/20 0.52
GAA P10253 1/20 0.47
TP53 P04637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
PRKACA P17612 3/20 0.45
PRKX P51817 2/20 0.45
PRKCQ Q04759 2/20 0.45
GRK5 P34947 1/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
YTHDC1 Q96MU7 1/20 0.42
AURKA O14965 1/20 0.41
LPO P22079 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974018 0.92 GAA (0.53) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7985850 0.91 GAA (0.49) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7987433 0.89 ROCK2 (0.54) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7988750 0.89 GAA (0.46) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7984696 0.88 GAA (0.47) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7985653 0.87 GAA (0.46) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7988747 0.86 CYP11B1 (0.44) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL7974093 0.86 GAA (0.48) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7974314 0.86 GAA (0.46) ROCK2ROCK1GAATP53RXFP1
SCHEMBL7974584 0.85 GAA (0.56) GAATP53RXFP1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed